ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- ViewsML, a company building the computational layer for biomarker discovery by...

ViewsML secures $4.9 million to help scientists virtually analyze tissue samples

ViewsML wants to make it easier for clinicians and scientists to extract insights from human tissue samples outside the laboratory with the help of AI. The Vancouver-based startup announced today that it has closed $4.9 million CAD in seed funding to execute on that vision and commercialize its platform.  ViewsML is developing AI models designed to derive biomarker insights—health indicators such as the presence of a certain nutrient in blood or…